Helen of Troy Limited

Helen of Troy Limited Q2 2027 Earnings Recap

HELE Q2 2027 October 10, 2026

Get alerts when HELE reports next quarter

Set up alerts — free

Helen of Troy beat its own outlook for adjusted EPS while sales were in line, and the stock rose 3.8% after earnings. Growth across Home & Outdoor brands, Wellness and Olive & June, alongside lower leverage, were positives; the company also cautioned that its recovery will not be linear and that some Beauty brands still face softer demand.

Earnings Per Share Beat
$0.79 vs $0.50 est.
+58.8% surprise
Revenue Miss
440926000 vs 442332600 est.
-0.3% surprise

Market Reaction

Post-Earnings +3.76%
Oct 12 to Oct 20 +3.26%

See HELE alongside your other holdings

Add to your portfolio — free

Key Takeaways

  • Q2 sales were in line with the company’s outlook; adjusted diluted EPS came in ahead.
  • Sales grew year over year across all three Home & Outdoor brands. Osprey led growth, while OXO and Hydro Flask benefited from targeted inventory actions and new products.
  • Wellness growth was driven primarily by Vicks and Braun; Olive & June also had another solid quarter, supported by consumer demand and expanded distribution.
  • International sales grew 3.7%. First-half free cash flow was $38 million, and net leverage fell to 3.0x from 3.5x at the end of Q1.
  • Retail inventory coverage improved year over year, but pockets of elevated inventory remain; some Beauty brands continue to see softer demand, and management said recovery will not be linear.
This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit HELE on AllInvestView.

Get the Full Picture on HELE

Track Helen of Troy Limited in your portfolio with real-time analytics, dividend tracking, and more.

View HELE Analysis